Comprehensive Haematological Malignancy Panel

Introduction to Haematological Malignancy Panels

A comprehensive haematological malignancy panel is a vital diagnostic tool used to detect and analyze various types of blood cancers. These panels encompass a wide range of tests designed to identify genetic mutations and abnormalities in the blood cells.

Components of the Panel

The comprehensive haematological malignancy panel includes tests for common haematological malignancies such as leukemia, lymphoma, and myeloma. By examining DNA and RNA from blood or bone marrow samples, it provides a thorough analysis of genetic markers.

Benefits of the Panel

Using a comprehensive haematological malignancy panel allows for precise diagnosis and personalized treatment plans. It helps in monitoring disease progression and response to therapy, ensuring optimal patient care.